DermTech, Inc. Profile Avatar - Palmy Investing

DermTech, Inc.

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expr…

Medical - Diagnostics & Research
US, La Jolla [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of DMTK's Analysis
CIK: 1651944 CUSIP: 24984K105 ISIN: US24984K1051 LEI: - UEI: -
Secondary Listings
DMTK has no secondary listings inside our databases.